Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 4Breast Neoplasms 3Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Fatigue 1Esophageal Squamous Cell Carcinoma 1Esophageal Diseases 1Digestive System Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 2Everolimus 2sintilimab 1Vitamin D 1S 1 (combination) 1Radiofrequency Ablation 1Radiation 1Photochemotherapy 1Neoadjuvant Therapy 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Congresses as Topic 1Capecitabine 1Calcitriol 1Ambulatory Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Cholangiocarcinoma × Radiation × Clear all
NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial Hospital

Phase 3 Unknown
155 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡